FOSTER CITY, Calif.--(BUSINESS WIRE)--Research related to the roles that small non-coding RNA molecules play in living cells is one of the fastest growing areas in biology. For these kinds of studies, researchers analyze large numbers of biological samples to examine how patterns of differentially expressed RNAs influence cellular processes related to basic biology and complex diseases such as cancer. To enable scientists to rapidly discover and profile novel small RNA molecules without requiring prior knowledge of sequence information, Applied Biosystems Inc. (NYSE:ABI) today announced the commercial availability of a new small RNA expression analysis solution optimized for the SOLiD™ System, the company’s ultra-high-throughput platform for DNA sequencing and genomic analysis research. This solution includes a multiplexing technology (also known as barcoding) that enables the simultaneous analysis of up to 256 biological samples in a single sequencing run. The multiplexing technology is currently available in limited release through an early access program.
